Please note: This trial has finished recruiting and is not accepting new participants.
Research Centre: Adelaide Institute for Sleep Health (AISH), Flinders University SA
Location: Mark Oliphant Building, 5 Laffer Drive, Bedford Park SA 5042, Australia
Lead Doctor: Prof. Sutapa Mukherjee
Ethics Committee: This study has been reviewed and approved by Bellberry Limited Human Research Ethics Committee
Background
Obstructive sleep apnoea (OSA) is a very common, chronic respiratory sleep disorder presented as frequent disruptions and/or pauses to breathing during sleep. Typical symptoms of OSA include daytime sleepiness, tiredness and fatigue, snoring, morning headaches, witnessed apnoeas, disrupted and non-restorative sleep, which may negatively affect quality of life.
This study seeks to investigate the potential benefit of a potential therapy for OSA with the hopes of finding an alternative treatment treatment that more people with OSA can easily use to help them breath normally during sleep, prevent snoring and wake up refreshed.
This study seeks adults aged 18 years old and above who have been diagnosed with sleep apnoea . Participants are required to attend 7 visits at the research site over approximately 6 weeks (or more) and may be compensated. Participating in this study will help us understand how this new OSA potential therapy can potentially manage sleep apnoea symptoms and prevent further complications.
Why Participate?
- You will contribute to the development of a potential therapy to help people with OSA.
- You may contribute to preventing further health complications brought about by OSA.
- You will be compensated for participating in this study.
- You will be helping to advance medical research.
Your Rights
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Adults aged 18 years old and above who have been diagnosed with sleep apnoea
- Able to attend 7 visits at the research site over approximately 6 weeks or more